This compound is primarily used in the synthesis of peptides and peptidomimetics, serving as a key intermediate in the development of pharmaceutical agents. It is particularly valuable in the preparation of modified amino acids, which are crucial for creating peptide-based drugs with enhanced stability and bioavailability. The benzyloxycarbonyl (Cbz) protecting group in the molecule allows for selective deprotection during peptide synthesis, enabling precise control over the assembly of complex peptide structures. Additionally, its chiral center makes it useful in the production of enantiomerically pure compounds, which are essential for drugs targeting specific biological pathways with minimal side effects.